Related references
Note: Only part of the references are listed.Association of Influenza Vaccination With Cardiovascular Risk A Meta-analysis
Bahar Behrouzi et al.
JAMA NETWORK OPEN (2022)
Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study
Michael Asger Andersen et al.
CLINICAL INFECTIOUS DISEASES (2021)
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
Donald Hurley et al.
CLINICAL INFECTIOUS DISEASES (2021)
Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
Naim Ouldali et al.
LANCET INFECTIOUS DISEASES (2021)
Adults at risk of pneumococcal disease in France
B. Wyplosz et al.
INFECTIOUS DISEASES NOW (2021)
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2018
Peng-Jun Lu et al.
MMWR SURVEILLANCE SUMMARIES (2021)
Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
Jeffrey Vietri et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups
Lise Boey et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
The Effect of Pay-for-Performance Compensation Model Implementation on Vaccination Rate: A Systematic Review
Roshanak Benabbas et al.
QUALITY MANAGEMENT IN HEALTH CARE (2019)
Pneumococcal Vaccine Coverage in Adults Aged 19-64 Years, Newly Diagnosed With Chronic Conditions in the U.S
Tanaz Petigara et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2018)
Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance
Dominique Rey et al.
Eurosurveillance (2018)
A systematic review of strategies for reducing missed opportunities for vaccination
Anelisa Jaca et al.
VACCINE (2018)
Vaccination of COPD patients: From guidelines to routine practise
E. Blanchard et al.
REVUE DES MALADIES RESPIRATOIRES (2018)
Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases
Kentaro Imai et al.
BMJ OPEN (2018)
Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination
Francesco Blasi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mohsen Naghavi et al.
LANCET (2017)
Value of a national administrative database to guide public decisions: From the systeme national d'information interregimes de l'Assurance Maladie (SNIIRAM) to the systeme national des donnees de sante (SNDS) in France
P. Tuppin et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2017)
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial
Opokua Ofori-Anyinam et al.
VACCINE (2017)
Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly
Susanne M. Huijts et al.
VACCINE (2017)
The full benefits of adult pneumococcal vaccination: A systematic review
Elizabeth T. Cafiero-Fonseca et al.
PLOS ONE (2017)
Vaccine Education of Medical Students: A Nationwide Cross-sectional Survey
Solen Kerneis et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2017)
Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions
Derek Weycker et al.
BMC HEALTH SERVICES RESEARCH (2016)
Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake
Amalie Dyda et al.
BMC INFECTIOUS DISEASES (2016)
Prevalence and correlates of vaccine hesitancy among general practitioners: a cross-sectional telephone survey in France, April to July 2014
P. Verger et al.
Eurosurveillance (2016)
The commitment of French general practitioners to vaccination: the DIVA study (Determinants of Vaccination Intentions)
Luc Martinez et al.
SANTE PUBLIQUE (2016)
Vaccine hesitancy among healthcare workers in Europe: A qualitative study
Emilie Karafillakis et al.
VACCINE (2016)
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency
Paul Loubet et al.
VACCINE (2015)
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
Kimberly M. Shea et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Vaccination coverage against influenza and pneumococcus for patients admitted to a pulmonary care service
F. Vandenbos et al.
REVUE DES MALADIES RESPIRATOIRES (2013)
Improving the vaccination coverage against influenza and Streptococcus pneumonia in the populations at risk: The role of pulmonary care services
O. Launay
REVUE DES MALADIES RESPIRATOIRES (2013)
Share Paper
